Creganna-Tactx Medical has a new Chairman
24/05/2012
Scott R. Ward has been
appointed Chairman of Creganna-Tactx Medical. He will succeed Ian Quinn, the
company founder, who will continue as a non-executive director of the Board.
Scott Ward, who has had a
long career in the medical device industry, first joined the Board of
Creganna-Tactx Medical in 2011. As former Vice President & President of
Medtronic CardioVascular, he was responsible for the worldwide operations of
the Coronary, Peripheral, Endovascular and Structural Heart Disease business
units at the company.
Welcoming his appointment,
Mr Ward said, "I look forward to working closely with the Management and Board
to deliver the company’s next phase of growth. Building on its current market
leadership positions, the company is well placed to explore new avenues for
development and expansion in a dynamic market environment.”
Helen Ryan, Creganna-Tactx
Medical CEO said, "I would like to thank Mr Quinn for his support over the past
eight years and I look forward to working with Mr Ward as our new Chairman. He
brings a wealth of industry knowledge and experience which will be of great
benefit to the management team as we embark on a new phase in the development of
the business.”
In addition to his
appointment as Chairman of the Creganna-Tactx Medical Board, Mr Ward is
Chairman to the Board of MAP Pharmaceuticals Inc and Gillette Children’s
Specialty Healthcare and a member of the Board of SurModics Inc.
Creganna-Tactx Medical is
ranked among the top 10 global companies in the medical device outsourcing
industry. It specialises in technologies, products and services for minimally
invasive device solutions. Headquartered in Galway, Ireland, the company has facilities spanning US, Europe and Asia.
Related News
Creganna-Tactx Medical acquires ABT Medical
05/10/2012
Creganna-Tactx Medical acquires to enhance its existing balloon design and manufacturing capabilities.... read more >
